🩸🎥 Approaching TP53-mutated AML: current challenges, ongoing research & novel therapeutic strategies.
Don't miss this insightful roundtable discussion from #iwAL25 with leading experts Eunice Wang, David Sallman, Gabriel Mannis, & Andrew Wei.
Watch now: 👉 buff.ly/VJJUbmz
#AMLsm #Leusm #Leukemia
In an interview from #iwAL25, Tara Lin discusses the possibility of tailoring treatment for secondary AML dependent on mutational profile, highlighting the heterogeneity of this disease.
Watch here:
👉 buff.ly/HbJTfmF 👈
#AMLsm #Leusm #Leukemia #HemOnc #BloodSky
#iwAL25 | John DiPersio comments on the challenges of treating T-cell malignancies with bispecific antibody therapy, and shares insights into the development of WU-CART-007, an anti-CD7 allogeneic CAR T-cell product:
🎥 buff.ly/s2zXiCa
#ALLsm #Leusm #ImmunoOnc #HemOnc #BloodSky #HemeSky #MedSky
Want to hear about the evolving role of menin inhibitors in AML?🩸
Don't miss our roundtable discussion on this topic from #iwAL25, featuring leading experts Naval Daver, @leukdocjz.bsky.social, Eytan Stein, & Amir Fathi.
Watch here: 👉 buff.ly/iaEfMsV
#AMLsm #Leusm #HemOnc #BloodSky #HemeSky
#iwAL25 | Charlie Craddock answers YOUR transplantation questions in a special Ask the Expert session!
Watch here:
👉 buff.ly/TRqoc4q%F0%9...
#HemOnc #ImmunoOnc #AMLsm #BMTsm #Leusm #BloodSky #HemeSky #MedSky
🎥 Sanam Loghavi and Guillermo Montalban-Bravo of @mdanderson.bsky.social sat down at #iwAL25 to share insights into the diagnosis and classification of CMML, commenting on how the current approach to this could be refined:
👉 buff.ly/5ZwQxnP 👈
#Leusm #HemOnc #RareDisease #MDSsm #BloodSky #HemeSky
